Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1993 Apr;56(4):334–343. doi: 10.1136/jnnp.56.4.334

Acute neuromuscular respiratory paralysis.

R A Hughes 1, D Bihari 1
PMCID: PMC1014946  PMID: 8482951

Full text

PDF
336

Images in this article

343Image
on p.343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. W., Kelly J. J., Jr Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989 Jun;12(6):435–451. doi: 10.1002/mus.880120602. [DOI] [PubMed] [Google Scholar]
  2. Arsura E. L., Bick A., Brunner N. G., Grob D. Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. Am J Med Sci. 1988 May;295(5):438–443. doi: 10.1097/00000441-198805000-00005. [DOI] [PubMed] [Google Scholar]
  3. Arsura E. L., Bick A., Brunner N. G., Namba T., Grob D. High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med. 1986 Jul;146(7):1365–1368. [PubMed] [Google Scholar]
  4. Azar I. The response of patients with neuromuscular disorders to muscle relaxants: a review. Anesthesiology. 1984 Aug;61(2):173–187. doi: 10.1097/00000542-198408000-00011. [DOI] [PubMed] [Google Scholar]
  5. Black L. F., Hyatt R. E. Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis. 1971 May;103(5):641–650. doi: 10.1164/arrd.1971.103.5.641. [DOI] [PubMed] [Google Scholar]
  6. Bolton C. F., Gilbert J. J., Hahn A. F., Sibbald W. J. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984 Nov;47(11):1223–1231. doi: 10.1136/jnnp.47.11.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Borel C. O., Tilford C., Nichols D. G., Hanley D. F., Traystman R. J. Diaphragmatic performance during recovery from acute ventilatory failure in Guillain-Barré syndrome and myasthenia gravis. Chest. 1991 Feb;99(2):444–451. doi: 10.1378/chest.99.2.444. [DOI] [PubMed] [Google Scholar]
  8. Bournaud R., Mallart A. Potassium channel blockers and impulse propagation in murine motor endplate disease. Muscle Nerve. 1987 Jan;10(1):1–5. doi: 10.1002/mus.880100103. [DOI] [PubMed] [Google Scholar]
  9. Braun N. M., Arora N. S., Rochester D. F. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax. 1983 Aug;38(8):616–623. doi: 10.1136/thx.38.8.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brust J. C., Hammer J. S., Challenor Y., Healton E. B., Lesser R. P. Acute generalized polyneuropathy accompanying lithium poisoning. Ann Neurol. 1979 Oct;6(4):360–362. doi: 10.1002/ana.410060410. [DOI] [PubMed] [Google Scholar]
  11. Calderon-Gonzalez R., Rizzi-Hernandez H. Buckthorn polyneuropathy. N Engl J Med. 1967 Jul 13;277(2):69–71. doi: 10.1056/NEJM196707132770204. [DOI] [PubMed] [Google Scholar]
  12. Calderón-González R., González-Cantu N., Rizzi-Hernandez H. Recurrent polyneuropathy with pregnancy and oral contraceptives. N Engl J Med. 1970 Jun 4;282(23):1307–1308. doi: 10.1056/NEJM197006042822308. [DOI] [PubMed] [Google Scholar]
  13. Cavanagh J. B., Fuller N. H., Johnson H. R., Rudge P. The effects of thallium salts, with particular reference to the nervous system changes. A report of three cases. Q J Med. 1974 Apr;43(170):293–319. [PubMed] [Google Scholar]
  14. Ciaglia P., Graniero K. D. Percutaneous dilatational tracheostomy. Results and long-term follow-up. Chest. 1992 Feb;101(2):464–467. doi: 10.1378/chest.101.2.464. [DOI] [PubMed] [Google Scholar]
  15. Cosi V., Lombardi M., Piccolo G., Erbetta A. Treatment of myasthenia gravis with high-dose intravenous immunoglobulin. Acta Neurol Scand. 1991 Aug;84(2):81–84. doi: 10.1111/j.1600-0404.1991.tb04912.x. [DOI] [PubMed] [Google Scholar]
  16. Dalos N. P., Borel C., Hanley D. F. Cardiovascular autonomic dysfunction in Guillain-Barré syndrome. Therapeutic implications of Swan-Ganz monitoring. Arch Neurol. 1988 Jan;45(1):115–117. doi: 10.1001/archneur.1988.00520250125034. [DOI] [PubMed] [Google Scholar]
  17. Danon M. J., Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve. 1991 Nov;14(11):1131–1139. doi: 10.1002/mus.880141115. [DOI] [PubMed] [Google Scholar]
  18. Dau P. C. Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients. Arch Neurol. 1981 Sep;38(9):544–552. doi: 10.1001/archneur.1981.00510090038003. [DOI] [PubMed] [Google Scholar]
  19. DeVere R., Bradley W. G. Polymyositis: its presentation, morbidity and mortality. Brain. 1975 Dec;98(4):637–666. doi: 10.1093/brain/98.4.637. [DOI] [PubMed] [Google Scholar]
  20. Deitch E. A. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg. 1990 Mar;125(3):403–404. doi: 10.1001/archsurg.1990.01410150125024. [DOI] [PubMed] [Google Scholar]
  21. Detsky A. S. Parenteral nutrition--is it helpful? N Engl J Med. 1991 Aug 22;325(8):573–575. doi: 10.1056/NEJM199108223250808. [DOI] [PubMed] [Google Scholar]
  22. Donat J. R., Donat J. F. Tick paralysis with persistent weakness and electromyographic abnormalities. Arch Neurol. 1981 Jan;38(1):59–61. doi: 10.1001/archneur.1981.00510010085020. [DOI] [PubMed] [Google Scholar]
  23. Freeman J., Goldmann D. A., Smith N. E., Sidebottom D. G., Epstein M. F., Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med. 1990 Aug 2;323(5):301–308. doi: 10.1056/NEJM199008023230504. [DOI] [PubMed] [Google Scholar]
  24. Goode G. B., Shearn D. L. Botulism: a case with associated sensory abnormalities. Arch Neurol. 1982 Jan;39(1):55–55. doi: 10.1001/archneur.1982.00510130057015. [DOI] [PubMed] [Google Scholar]
  25. Gould D. B., Sorrell M. R., Lupariello A. D. Barium sulfide poisoning. Some factors contributing to survival. Arch Intern Med. 1973 Dec;132(6):891–894. doi: 10.1001/archinte.132.6.891. [DOI] [PubMed] [Google Scholar]
  26. Greenberg C., Davies S., McGowan T., Schorer A., Drage C. Acute respiratory failure following severe arsenic poisoning. Chest. 1979 Nov;76(5):596–598. doi: 10.1378/chest.76.5.596. [DOI] [PubMed] [Google Scholar]
  27. Grover E. R., Bihari D. J. The role of tracheostomy in the adult intensive care unit. Postgrad Med J. 1992 May;68(799):313–317. doi: 10.1136/pgmj.68.799.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hall A. J. Polio eradication as 2000 approaches. BMJ. 1992 Jul 11;305(6845):69–70. doi: 10.1136/bmj.305.6845.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hall S. M., Hughes R. A., Atkinson P. F., McColl I., Gale A. Motor nerve biopsy in severe Guillain-Barré syndrome. Ann Neurol. 1992 Apr;31(4):441–444. doi: 10.1002/ana.410310416. [DOI] [PubMed] [Google Scholar]
  30. Hughes J. M., Blumenthal J. R., Merson M. H., Lombard G. L., Dowell V. R., Jr, Gangarosa E. J. Clinical features of types A and B food-borne botulism. Ann Intern Med. 1981 Oct;95(4):442–445. doi: 10.7326/0003-4819-95-4-442. [DOI] [PubMed] [Google Scholar]
  31. Hughes R. A., Cameron J. S., Hall S. M., Heaton J., Payan J., Teoh R. Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus--nerve biopsy and response to plasma exchange. J Neurol. 1982;228(4):239–247. doi: 10.1007/BF00313414. [DOI] [PubMed] [Google Scholar]
  32. Hughes R. A. Ineffectiveness of high-dose intravenous methylprednisolone in Guillain-Barré syndrome. Lancet. 1991 Nov 2;338(8775):1142–1142. doi: 10.1016/0140-6736(91)91995-7. [DOI] [PubMed] [Google Scholar]
  33. Hughes R. A., Newsom-Davis J. M., Perkin G. D., Pierce J. M. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978 Oct 7;2(8093):750–753. doi: 10.1016/s0140-6736(78)92644-2. [DOI] [PubMed] [Google Scholar]
  34. Hughes R., Atkinson P., Coates P., Hall S., Leibowitz S. Sural nerve biopsies in Guillain-Barre syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome. Muscle Nerve. 1992 May;15(5):568–575. doi: 10.1002/mus.880150506. [DOI] [PubMed] [Google Scholar]
  35. Jann S., Beretta S., Moggio M., Adobbati L., Pellegrini G. High-dose intravenous human immunoglobulin in polymyositis resistant to treatment. J Neurol Neurosurg Psychiatry. 1992 Jan;55(1):60–62. doi: 10.1136/jnnp.55.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Joce R., Wood D., Brown D., Begg N. Paralytic poliomyelitis in England and Wales, 1985-91. BMJ. 1992 Jul 11;305(6845):79–82. doi: 10.1136/bmj.305.6845.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kelly B. J., Luce J. M. The diagnosis and management of neuromuscular diseases causing respiratory failure. Chest. 1991 Jun;99(6):1485–1494. doi: 10.1378/chest.99.6.1485. [DOI] [PubMed] [Google Scholar]
  38. Keunen R. W., Lambregts P. C., Op de Coul A. A., Joosten E. M. Respiratory failure as initial symptom of acid maltase deficiency. J Neurol Neurosurg Psychiatry. 1984 May;47(5):549–552. doi: 10.1136/jnnp.47.5.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Knaus W. A., Wagner D. P., Draper E. A., Zimmerman J. E., Bergner M., Bastos P. G., Sirio C. A., Murphy D. J., Lotring T., Damiano A. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991 Dec;100(6):1619–1636. doi: 10.1378/chest.100.6.1619. [DOI] [PubMed] [Google Scholar]
  40. Krendel D. A., Stahl R. L., Chan W. C. Lymphomatous polyneuropathy. Biopsy of clinically involved nerve and successful treatment. Arch Neurol. 1991 Mar;48(3):330–332. doi: 10.1001/archneur.1991.00530150102026. [DOI] [PubMed] [Google Scholar]
  41. Lindesmith L. A., Baines R. D., Jr, Bigelow D. B., Petty T. L. Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med. 1968 Feb;68(2):318–327. doi: 10.7326/0003-4819-68-2-318. [DOI] [PubMed] [Google Scholar]
  42. Mastaglia F. L., Ojeda V. J. Inflammatory myopathies: Part 1. Ann Neurol. 1985 Mar;17(3):215–227. doi: 10.1002/ana.410170302. [DOI] [PubMed] [Google Scholar]
  43. Maynard N. D., Bihari D. J. Postoperative feeding. BMJ. 1991 Oct 26;303(6809):1007–1008. doi: 10.1136/bmj.303.6809.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. McKhann G. M., Griffin J. W., Cornblath D. R., Mellits E. D., Fisher R. S., Quaskey S. A. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol. 1988 Apr;23(4):347–353. doi: 10.1002/ana.410230406. [DOI] [PubMed] [Google Scholar]
  45. Miller F. W., Leitman S. F., Cronin M. E., Hicks J. E., Leff R. L., Wesley R., Fraser D. D., Dalakas M., Plotz P. H. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med. 1992 May 21;326(21):1380–1384. doi: 10.1056/NEJM199205213262102. [DOI] [PubMed] [Google Scholar]
  46. Mills A. R., Passmore R. Pelagic paralysis. Lancet. 1988 Jan 23;1(8578):161–164. doi: 10.1016/s0140-6736(88)92729-8. [DOI] [PubMed] [Google Scholar]
  47. Mitchell G., Larochelle J., Lambert M., Michaud J., Grenier A., Ogier H., Gauthier M., Lacroix J., Vanasse M., Larbrisseau A. Neurologic crises in hereditary tyrosinemia. N Engl J Med. 1990 Feb 15;322(7):432–437. doi: 10.1056/NEJM199002153220704. [DOI] [PubMed] [Google Scholar]
  48. Mohamed S. D., Chapman R. S., Crooks J. Hypokalaemia, flaccid quadruparesis, and myoglobinuria with carbenoxolone (biogastrone). Br Med J. 1966 Jun 25;1(5503):1581–1582. doi: 10.1136/bmj.1.5503.1581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Newman J. H., Neff T. A., Ziporin P. Acute respiratory failure associated with hypophosphatemia. N Engl J Med. 1977 May 12;296(19):1101–1103. doi: 10.1056/NEJM197705122961908. [DOI] [PubMed] [Google Scholar]
  50. Norman M., Elinder G., Finkel Y. Vincristine neuropathy and a Guillain-Barré syndrome: a case with acute lymphatic leukemia and quadriparesis. Eur J Haematol. 1987 Jul;39(1):75–76. doi: 10.1111/j.1600-0609.1987.tb00168.x. [DOI] [PubMed] [Google Scholar]
  51. Osterman P. O., Fagius J., Säfwenberg J., Danielsson B. G., Wikström B. Early relapses after plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1986 Nov 15;2(8516):1161–1161. doi: 10.1016/s0140-6736(86)90570-2. [DOI] [PubMed] [Google Scholar]
  52. Pedersen J., Schurizek B. A., Melsen N. C., Juhl B. The effect of nasotracheal intubation on the paranasal sinuses. A prospective study of 434 intensive care patients. Acta Anaesthesiol Scand. 1991 Jan;35(1):11–13. doi: 10.1111/j.1399-6576.1991.tb03233.x. [DOI] [PubMed] [Google Scholar]
  53. Pingleton S. K., Harmon G. S. Nutritional management in acute respiratory failure. JAMA. 1987 Jun 12;257(22):3094–3099. [PubMed] [Google Scholar]
  54. Raphael J. C., Chastang C., Chevret S., Gajdos P. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome. N Engl J Med. 1992 Sep 10;327(11):816–817. doi: 10.1056/NEJM199209103271117. [DOI] [PubMed] [Google Scholar]
  55. Rappuoli R., Perugini M., Falsen E. Molecular epidemiology of the 1984-1986 outbreak of diphtheria in Sweden. N Engl J Med. 1988 Jan 7;318(1):12–14. doi: 10.1056/NEJM198801073180103. [DOI] [PubMed] [Google Scholar]
  56. Ropper A. E., Albert J. W., Addison R. Limited relapse in Guillain-Barré syndrome after plasma exchange. Arch Neurol. 1988 Mar;45(3):314–315. doi: 10.1001/archneur.1988.00520270096026. [DOI] [PubMed] [Google Scholar]
  57. Roussos C., Macklem P. T. The respiratory muscles. N Engl J Med. 1982 Sep 23;307(13):786–797. doi: 10.1056/NEJM198209233071304. [DOI] [PubMed] [Google Scholar]
  58. Selective digestive decontamination in intensive care unit patients. Intensive Care Med. 1992;18(3):182–188. doi: 10.1007/BF01709246. [DOI] [PubMed] [Google Scholar]
  59. Senanayake N., Johnson M. K. Acute polyneuropathy after poisoning by a new organophosphate insecticide. N Engl J Med. 1982 Jan 21;306(3):155–157. doi: 10.1056/NEJM198201213060306. [DOI] [PubMed] [Google Scholar]
  60. Senanayake N., Román G. C. Disorders of neuromuscular transmission due to natural environmental toxins. J Neurol Sci. 1992 Jan;107(1):1–13. doi: 10.1016/0022-510x(92)90202-v. [DOI] [PubMed] [Google Scholar]
  61. Sitwell L. D., Weinshenker B. G., Monpetit V., Reid D. Complete ophthalmoplegia as a complication of acute corticosteroid- and pancuronium-associated myopathy. Neurology. 1991 Jun;41(6):921–922. doi: 10.1212/wnl.41.6.921. [DOI] [PubMed] [Google Scholar]
  62. Swift T. R. Weakness from magnesium-containing cathartics: electrophysiologic studies. Muscle Nerve. 1979 Jul-Aug;2(4):295–298. doi: 10.1002/mus.880020409. [DOI] [PubMed] [Google Scholar]
  63. Thomas P. K. The Guillain-Barré syndrome: no longer a simple concept. J Neurol. 1992 Aug;239(7):361–362. doi: 10.1007/BF00812150. [DOI] [PubMed] [Google Scholar]
  64. Trend P. S., Wiles C. M., Spencer G. T., Morgan-Hughes J. A., Lake B. D., Patrick A. D. Acid maltase deficiency in adults. Diagnosis and management in five cases. Brain. 1985 Dec;108(Pt 4):845–860. doi: 10.1093/brain/108.4.845. [DOI] [PubMed] [Google Scholar]
  65. Tuck R. R., McLeod J. G. Autonomic dysfunction in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1981 Nov;44(11):983–990. doi: 10.1136/jnnp.44.11.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Vernay D., Dubost J. J., Thevenet J. P., Sauvezie B., Rampon S. "Chorée fibrillaire de Morvan" followed by Guillain-Barré syndrome in a patient receiving gold therapy. Arthritis Rheum. 1986 Nov;29(11):1413–1414. doi: 10.1002/art.1780291119. [DOI] [PubMed] [Google Scholar]
  67. Vital C., Vital A., Julien J., Rivel J., deMascarel A., Vergier B., Henry P., Barat M., Reiffers J., Broustet A. Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification. J Neurol. 1990 Jun;237(3):177–185. doi: 10.1007/BF00314591. [DOI] [PubMed] [Google Scholar]
  68. Watt G., Theakston R. D., Hayes C. G., Yambao M. L., Sangalang R., Ranoa C. P., Alquizalas E., Warrell D. A. Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). A placebo-controlled study. N Engl J Med. 1986 Dec 4;315(23):1444–1448. doi: 10.1056/NEJM198612043152303. [DOI] [PubMed] [Google Scholar]
  69. Wilder-Smith E., Roelcke U. Meningopolyradiculitis (Bannwarth syndrome) as primary manifestation of a centrocytic-centroblastic lymphoma. J Neurol. 1989 Mar;236(3):168–169. doi: 10.1007/BF00314335. [DOI] [PubMed] [Google Scholar]
  70. Wilmore D. W. Catabolic illness. Strategies for enhancing recovery. N Engl J Med. 1991 Sep 5;325(10):695–702. doi: 10.1056/NEJM199109053251005. [DOI] [PubMed] [Google Scholar]
  71. Winer J. B., Hughes R. A. Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome. Q J Med. 1988 Sep;68(257):735–739. [PubMed] [Google Scholar]
  72. Zochodne D. W., Bolton C. F., Wells G. A., Gilbert J. J., Hahn A. F., Brown J. D., Sibbald W. A. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain. 1987 Aug;110(Pt 4):819–841. doi: 10.1093/brain/110.4.819. [DOI] [PubMed] [Google Scholar]
  73. van der Meché F. G., Schmitz P. I. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med. 1992 Apr 23;326(17):1123–1129. doi: 10.1056/NEJM199204233261705. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES